XML 56 R35.htm IDEA: XBRL DOCUMENT v3.21.1
Stock Incentive Plan (Tables)
12 Months Ended
Jan. 30, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The fair value of options is estimated as of the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:
  Fiscal Year Ended
  January 30,
2021
February 1,
2020
February 2,
2019
Risk-free interest rate0.28 %1.65 %2.88 %
Dividend yield(a)
1.4 %1.6 %1.4 %
Expected volatility factor26.5 %23.4 %23.5 %
Expected option life5.0 years4.9 years4.9 years
Weighted average fair value of options issued$11.29 $10.84 $11.85 
(a)The reduction in the yield reflects the temporary suspension of dividends due to the COVID-19 pandemic. TJX calculated an implied dividend yield of 1.4% by anticipating dividends to resume. The decrease in expected dividend yield reflects the suspension of dividend payments during the first nine months of fiscal 2021.
Schedule of Stock Options and Related Weighted Average Exercise Prices
A summary of the status of TJX’s stock options and related weighted average exercise prices (“WAEP”) is presented below:
  Fiscal Year Ended
Shares in thousandsJanuary 30,
2021
February 1,
2020
February 2,
2019
  OptionsWAEPOptionsWAEPOptionsWAEP
Outstanding at beginning of year45,065 $36.81 49,053 $32.02 55,260 $27.52 
Granted6,268 57.32 6,150 56.74 6,143 53.98 
Exercised(8,239)25.68 (9,518)24.40 (11,670)21.88 
Forfeitures(490)52.96 (620)46.37 (680)38.59 
Outstanding at end of year42,604 $41.79 45,065 $36.81 49,053 $32.02 
Options exercisable at end of year30,659 $36.05 32,276 $31.04 34,344 $26.95 
Schedule of Stock Options Outstanding Expected to Vest and Stock Options Outstanding Exercisable
The following table summarizes information about stock options outstanding that were expected to vest and stock options outstanding that were exercisable as of January 30, 2021:
Shares
(in thousands)
Aggregate
Intrinsic
Value
(in thousands)
Weighted
Average
Remaining
Contract Life
WAEP
Options outstanding expected to vest(a)
11,060 $82,510 9.0 years$56.58 
Options exercisable30,659 $858,015 5.0 years$36.05 
Total outstanding options vested and expected to vest41,719 $940,525 6.1 years$41.50 
(a)Reflects 11.9 million unvested options, net of anticipated forfeitures.
Summary of Nonvested Performance-Based Stock Awards
A summary of the status of our nonvested stock awards and changes during fiscal 2021 is presented below:
Stock Awards
(in thousands)
Weighted
Average
Grant Date
Fair Value
Nonvested at beginning of year3,445 $44.54 
Granted857 56.24 
Vested(1,317)43.25 
Forfeited(14)48.04 
Modification(50)52.17 
Nonvested at end of year2,921 51.36